Pseudomyogenic Hemangioendothelioma — Variants & evidence

Pseudomyogenic Hemangioendothelioma — Variants & evidence · CancerIndex

Variants & evidence

Curated clinical evidence by variant and therapy

3 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.

civicCuratedShowing 1–3 of 3 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
FOSB Fusion1
(diagnostic)	Diagnostic	B	Supports Positive	4	accepted	EID12779 In this 2019 study, targeted RNA sequencing using the Archer FusionPlex technology was validated and implemented to detect oncogenic fusion transcripts in 62 genes recurrently rearranged in solid tumo… (full text at CIViC) PMID 30459475 · Zhu et al., 2019 · Open in CIViC	civic
WWTR1 Fusion1
(diagnostic)	Diagnostic	C	Supports Positive	4	accepted	EID12752 In this study, the authors investigated a case of pseudomyogenic hemangioendothelioma in a 33-year-old woman presenting with multifocal lytic bone lesions. Previous studies had demonstrated recurrent … (full text at CIViC) PMID 31243110 · Panagopoulos et al., 2019 · Open in CIViC	civic
FOSB Fusion1
(diagnostic)	Diagnostic	B	Supports Positive	3	accepted	EID11785 In this study, the authors analyzed two index cases of pseudomyogenic haemangioendothelioma and 10 additional cases by interphase FISH. Both index cases showed a balanced t(7;19)(q22;q13) translocatio… (full text at CIViC) PMID 24374978 · Walther et al., 2014 · Open in CIViC	civic

Data updated 15 hours agoSource updated unknownsource: civic (CC0)

Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.